Showing results (581-590 of 722) with videos related to

Sort By:
Pageof 73
Journal of Arrhythmia|April 17, 2018
Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS)Satoshi Ogawa, Kazuo Minematsu, Takanori Ikeda, et al.
Brain Research|November 17, 2015
Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic strokeKuniyuki Nakamura, Koichi Arimura, Ataru Nishimura, et al.
Experimental Neurology|December 17, 2014
Involvement of platelet-derived growth factor receptor β in fibrosis through extracellular matrix protein production after ischemic strokeNoriko Makihara, Koichi Arimura, Tetsuro Ago, et al.
Internal Medicine (Tokyo, Japan)|June 14, 2021
Risk of Rebleeding in Patients with Small Bowel Vascular LesionsAkira Harada, Takehiro Torisu, Shin Fujioka, et al.
Kidney & Blood Pressure Research|March 7, 2021
Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover TrialTakaichi Suehiro, Kazuhiko Tsuruya, Hisako Yoshida, et al.
Clinical Nephrology|July 6, 2019
Hemodialysis treatment time versus erythropoietin dose requirement: Reduction in 2,000 units per week by extension of hemodialysis for 1 hourAtsuhiro Maeda, Kazuhiko Tsuruya, Maki Maeda, et al.
Kidney Medicine|August 1, 2020
Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 StudyTeppei Sakoh, Masatomo Taniguchi, Shunsuke Yamada, et al.
Neurology|July 9, 2020
Lifetime cumulative incidence of dementia in a community-dwelling elderly population in JapanDaigo Yoshida, Tomoyuki Ohara, Jun Hata, et al.
International Journal of Cardiology|August 24, 2023
Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND studyWataru Shimizu, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.
Journal of Atherosclerosis and Thrombosis|September 29, 2024
Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND StudyKoichi Kaikita, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.
Pageof 73